CIP
AMED

Convergence Investment Partners’s Amedisys AMED Stock Holding History

Convergence Investment Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,467
Closed -$178K – 299
2019
Q2 		$178K Sell
1,467
-14,508
-91% -$1.72M 0.04% 267
2019
Q1 		$1.97M Sell
15,975
-4,855
-23% -$609K 0.43% 78
2018
Q4 		$2.44M Buy
20,830
+15,318
+278% +$1.81M 0.56% 54
2018
Q3 		$689K Sell
5,512
-6,432
-54% -$710K 0.14% 177
2018
Q2 		$1.02M Buy
+11,944
New +$877K 0.14% 192
2016
Q1 		– Sell
-40,668
Closed -$1.6M – 328
2015
Q4 		$1.6M Sell
40,668
-9,864
-20% -$395K 0.18% 189
2015
Q3 		$1.92M Buy
+50,532
New +$2.13M 0.22% 154

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Convergence Investment Partners's AMED Position: Q3 2019 in Review

Convergence Investment Partners sold out of Amedisys (AMED) in Q3 2019, closing a stake of 1,467 shares — an estimated $178K sold.

Convergence Investment Partners first reported a position in AMED in Q3 2015 and held it in 7 quarters. The position peaked at $2.44M in Q4 2018. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

  • Convergence Investment Partners reported no remaining Amedisys position as of Q3 2019 after selling out during the quarter.
  • Convergence Investment Partners sold 1,467 Amedisys shares in Q3 2019, an estimated $178K.
  • Convergence Investment Partners first reported a position in Amedisys in Q3 2015 and held it in 7 quarters.
  • Convergence Investment Partners's Amedisys position peaked at $2.44M in Q4 2018.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Convergence Investment Partners's 13F filing for Q3 2019, filed 22 Oct 2019.